The TGA has given Australia’s first Omicron-specific COVID-19 vaccine the go-ahead, granting Moderna’s new bivalent vaccine conditional approval as a booster.

The vaccine, which targets the ancestal strain of SARS-CoV-2 plus the BA.1 Omicron variant, is approved for patients aged 18 or older, the TGA said in a statement on Tuesday.